NCT01380236 A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma Status WITHDRAWN Phase PHASE2
NCT01378039 Pathogenetic Mechanisms of Chronic Obstructive Pulmonary Diseases Status COMPLETED Phase NA
NCT01374932 CPASMA: Is There an Improvement in Asthma in Patients With Both Asthma and OSAS Treated With CPAP? Status UNKNOWN Phase PHASE3
NCT01370577 The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly Status COMPLETED Phase N/A
NCT01370317 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma Status COMPLETED Phase PHASE1
NCT01370031 Pilot Pharmacokinetic Clenil Study With AeroChamber Plus™ or Volumatic™ Spacer Devices Status COMPLETED Phase PHASE2
NCT01369810 Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT01366521 Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils Status COMPLETED Phase PHASE2
NCT01366222 Food Concentrates Supplementation to Alleviate Asthma in Children Status COMPLETED Phase NA
NCT01361139 Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD) Status COMPLETED Phase N/A
NCT01360021 New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day Status COMPLETED Phase PHASE3
NCT01357642 Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients Status COMPLETED Phase PHASE3
NCT01350414 AIR2 Extension Study to Demonstrate Longer-term (> 1 Year) Durability of Effectiveness Status COMPLETED Phase N/A
NCT01349257 Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI Status COMPLETED Phase PHASE2
NCT01348932 The Relationship Between Single Nucleotide Polymorphisms of Chitinase 3-like 1 Gene,YKL-40 Serum Levels and Adult Asthma Status UNKNOWN Phase N/A
NCT01348139 Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma Status COMPLETED Phase PHASE2